Moody's Investors Service has revised West Des Moines, Iowa-based UnityPoint Health's outlook to negative from stable.
The outlook revision is based on a number of factors, including UnityPoint's more modest operating cash flow margin in fiscal year 2015 and Moody's Investors Service's expectation of continued margin pressure.
Moody's also assigned an "Aa3" rating to UnityPoint's proposed $46 million of series 2016D bonds and $168 million of series 2016E bonds. The rating assignment reflects UnityPoint's size, market reach and track record of profitability.